Educational protocol hub
PNC-27: protocol variants and reconstitution resources
Educational hub for PNC-27, grouping 1 available protocol variant with links to the exact dosage and reconstitution pages.
What this hub covers
This page groups the available PNC-27 protocol variants so readers can choose the exact vial-size guide without mixing formats.
Reconstitution workflow
Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.
Research-only context
All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.
Available protocol variants
Choose the exact guide you want to view.
PNC-27
PNC-27 is an antineoplastic peptide that targets the HDM-2 receptor on cancer cells, inducing pore formation in their membrane and causing cell necrosis. It does not harm healthy cells. Research sources report subcutaneous administration of 100 mcg to 500 mcg, once daily, increased gradually.
View protocolRelated research resources
Internal links that help readers and search engines understand this peptide topic cluster.
References
- Davitt K et al. Ann Clin Lab Sci 2014 — The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells.
View Source - Sarafraz-Yazdi E et al. Biomedicines 2022 — PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis.
View Source
Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.